Interpreting cobalt blood concentrations in hip implant patients

Clinical Toxicology

Volumn 52, Issue 2, 2014, Pages 98-112

  Paustenbach, Dennis J ^a   Galbraith, David A ^a   Finley, Brent L ^a  

^a CARDNO CHEMRISK   (United States)

Author keywords

Arthroplasty; Chromium; Cobalt; Hip implant; Metal On Metal; Systemic toxicity

Indexed keywords

CHROMIUM; COBALT;

ACNE; ANOREXIA; BRAIN DYSFUNCTION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; COBALT BLOOD LEVEL; CORRELATION ANALYSIS; DERMATITIS; DISEASE PREDISPOSITION; ECZEMA; ENDOCRINE SYSTEM; HEALTH HAZARD; HIGH RISK PATIENT; HIP PROSTHESIS; HUMAN; HYPOALBUMINEMIA; HYPOTHYROIDISM; MECHANICAL STRESS; MEDLINE; NEUROLOGY; NEUROPATHY; NONHUMAN; POLYCYTHEMIA; RASH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SUSCEPTIBLE POPULATION; TISSUE INJURY;

ADMINISTRATION, ORAL; ANIMALS; COBALT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDPOINT DETERMINATION; HIP PROSTHESIS; HUMANS; HYPOTHYROIDISM; NEOPLASMS; POLYCYTHEMIA; RISK FACTORS;

EID: 84893504944     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2013.857024     Document Type: Review

References (176)

1. Coleman RF , Herrington J , Scales JT. Concentration of wear products in hair, blood, and urine after total hip replacement. Br Med J 1973 ; 1 : 527-529
2. Bartolozzi A , Black J. Chromium concentrations in serum, blood clot and urine from patients following total hip arthroplasty. Biomaterials 1985 ; 6 : 2-8
3. Michel R , Nolte M , Reich M , Loer F. Systemic effects of implanted prostheses made of cobalt-chromium alloys. Arch Orthop Trauma Surg 1991 ; 110 : 61-74
4. Jacobs JJ , Urban RM , Gilbert JL , Skipor AK , Black J , Jasty M , Galante JO. Local and distant products from modularity. Clin Orthop 1995 ; 319 : 94-105
5. Levine H , Ballard WT , Shanbhag A , Jacobs JJ. Particle debris. In: Callaghan JJ , Rosenberg AG , Rubash HE , eds. The Adult Hip Volume 1. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 2007 : 276-285
6. Smith-Petersen MN. Evolution of mould arthroplasty of the hip joint. J Bone Joint Surg Br 1948 ; 30 : 59-75
7. McKee GK , Watson-Farrar J. Replacement of arthritic hips by the McKee-Farrar prosthesis. J Bone Joint Surg Br 1966 ; 48 : 245-259
8. McKee GK , Chen SC. The statistics of the McKee-Farrar method of total hip replacement. Clin Orthop 1973 ; 95 : 26-33
9. August AC , Aldam CH , Pynsent PB. The McKee-Farrar hip arthroplasty. A long-term study. J Bone Joint Surg Br 1986 ; 68 : 520-527
10. D obbs H S. S urvivorship of total hip replacements. J Bone Joint Surg 1980; 62B: 168-173
11. Charnley J , Cupic Z. The nine and ten year results of the low-friction arthroplasty of the hip. Clin Orthop 1973 ; 95 : 9-25
12. Willert HG , Semlitsch M. Reactions of the articular capsule to wear products of artifi cial joint prostheses. J Biomed Mater Res 1977 ; 11 : 157-164
13. Weber BG. Experience with the Metasul total hip bearing system. Clin Orthop 1996 ; 329S : S69-S77
14. Jacobs JJ , Urban RM , Hallab NJ , Skipor AK , Fischer A , Wimmer MA. Metal-on-metal bearing surfaces. J Am Acad Orthop Surg 2009 ; 17 : 69-76
15. Amstutz HC , Grigoris P. Metal on metal bearings in hip arthroplasty. Clin Orthop 1996 ; 329 : S11-S34
16. Heaton KT , Dorr LD. Total hip arthroplasty with metasul articulation. Oper Tech Orthop 2001 ; 11 : 244-252
17. USFDA (United States Food and Drug Administration). R ecalls Specifi c to Metal-on-Metal Hip Implants. Retrieved on September 6, 2013, from: Http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ ImplantsandProsthetics/MetalonMetalHipImplants/ucm241770.htm#2. Silver Spring, MD: U.S. Food and Drug Administration; 2013
18. Antoniou J , Zukor DJ , Mwale F , Minarik W , Petit A , Huk OL. Metal ion levels in the blood of patients after hip resurfacing: A comparison between twenty-eight and thirty-six-millimeter-head metal-on-metal prostheses. J Bone Joint Surg Am 2008 ; 90 : 142-148
19. Clarke MT , Lee PT , Arora A , Villar RN. Levels of metal ions after small- and large-diameter metal-on-metal hip arthroplasty. J Bone Joint Surg Br 2003 ; 85 : 913-917
20. Back DL , Young DA , Shimmin AJ. How do serum cobalt and chromium levels change after metal-on-metal hip resurfacing? Clin Orthop 2005 ; 438 : 177-181
21. De Smet K , Calistri A , De Haan R , Campbell PA , Ebramzadeh E , Pattyn C , Gill HS. Metal ion measurement as a diagnostic tool to identify problems with metal-on-metal hip resurfacing. J Bone Joint Surg Am 2008 ; 90 : 202-208
22. Engh CA Jr , MacDonald S , Sritulanondha S , Thompson A , Naudie D , Engh C. Metal ion levels after metal-on-metal total hip arthroplasty: A randomized trial. Clin Orthop 2009 ; 467 : 101-111
23. Jacobs JJ , Skipor AK , Doorn PF , Campbell P , Schmalzried TP , Black J , Amstutz HC. Cobalt and chromium concentrations in patients with metal on metal total hip replacements. Clin Orthop 1996 ; 329 : S256-S263
24. Langton DJ , Jameson SS , Joyce TJ , Hallab NJ , Natu S , Nargol AV. Early failure of metal-on-metal bearings in hip resurfacing and large-diameter total hip replacement: A consequence of excess wear. J Bone Joint Surg Br 2010 ; 92 : 38-46
25. MacDonald S J. C an a safe level for metal ions in patients with metalon-metal total hip arthroplasties be determined? J Arthroplasty 2004 ; 19 : 71-77
26. Vendittoli PA , Mottard S , Roy AG , Dupont C , Lavigne M. Chromium and cobalt ion release following the Durom high carbon content, forged metal-on-metal surface replacement of the hip. J Bone Joint Surg Br 2007 ; 89 : 441-448
27. Walter LR , Marel E , Harbury R , Wearne J. Distribution of chromium and cobalt ions in various blood fractions after resurfacing hip arthroplasty. J Arthroplasty 2008 ; 23 : 814-821
28. Finley BL , Monnot AD , Gaffney SH , Paustenbach DJ. Dose-response relationships for blood cobalt concentrations and health effects: A review of the literature and application of a biokinetic model. J Tox Environ Health Part B 2012 ; 15 : 493-523
29. F inley B L, M onnot A D, P austenbach D J, G affney S H. D erivation of a chronic oral reference dose for cobalt. Regul Toxicol Pharmacol 2012 ; 64 : 491-503
30. Mayo Clinic. Test Catalog. Test ID: COS (80084) Cobalt, Serum. Retrieved on August 1, 2013, from: Http://www.mayomedicallaboratories. com/test-catalog/print/80084. 2013
31. P austenbach D J, T vermoes B E, U nice K M, F inley B L, K erger B D. A review of the health hazards posed by cobalt. Crit Rev Toxicol 2013; 43: 316-362
32. Mayo Clinic. Evaluation of metal-on-metal wear of orthopedic implants. The role of serum chromium and cobalt analysis. Communique 2012 ; 37 : 1-6
33. MHRA (Medicines and Healthcare Products Regulatory Agency). All Metal-On-Metal (MOM) Hip Replacements. London: MHRA ; 2012
34. Sampson B , Hart A. Clinical usefulness of blood metal measurements to assess the failure of metal-on-metal hip implants. Ann Clin Biochem 2012 ; 49 : 118-131
35. Hart AJ , Hester T , Sinclair K , Powell JJ , Goodship AE , Pele L , et al. The association between metal ions from hip resurfacing and reduced T-cell counts. J Bone Joint Surg Br 2006 ; 88 : 449-454
36. Hart AJ , Skinner JA , Winship P , Faria N , Kulinskaya E , Webster D , et al. Circulating levels of cobalt and chromium from metal-on-metal hip replacement are associated with CD8T-cell lymphopenia. J Bone Joint Surg Br 2009 ; 91 : 835-842
37. USFDA (United States Food and Drug Administration). I nformation for Orthopaedic Surgeons about Metal-on-Metal Hip Implant Surgery. Retrieved on September 3, 2013 , from: Http://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ ucm241667.htm. Silver Spring, MD: U.S. Food and Drug Administration ; 2013
38. Pritchett JW. Adverse reaction to metal debris: Metallosis of the resurfaced hip. Cur Orthop Pract 2012 ; 23 : 50-58
39. Langton DJ , Joyce TJ , Jameson SS , Lord J , Van Orsouw M , Holland JP , et al. Adverse reaction to metal debris following hip resurfacing: The infl uence of component type, orientation and volumetric wear. J Bone Joint Surg Br 2011 ; 93 : 164-171
40. Milosev I , Trebse R , Kovac S , Cor A , Campbell P. Dissociation of the metal inlay from the polyethylene liner in an uncemented threaded cup. Arch Orthop Trauma Surg 2005 ; 125 : 134-141
41. M atsuda Y , Y amamuro T , K asai R , M atsusue Y , O kumura H. S evere metallosis due to abnormal abrasion of the femoral head in a dual bearing hip prosthesis. A case report. J Arthroplasty 1992; 7: 439-445
42. Mohammed R , Cnudde P. Severe metallosis owing to intraprosthetic dislocation in a failed dual-mobility cup primary total hip arthroplasty. J Arthoplasty 2012 ; 27 : 493.e1-493.e3
43. Winter GD. Tissue reactions to metallic wear and corrosion products in human patients. J Biomed Mater Res 1974 ; 8 : 11-26
44. Liao Y , Hoffman E , Wimmer M , Fischer A , Jacobs J , Marks L. CoCrMo metal-on-metal hip replacements. Phys Chem Chem Phys 2013 ; 15 : 746-756
45. Catelas I , Medley JB , Campbell PA , Huk OL , Bobyn JD. Comparison of in vitro with in vivo characteristics of wear particles from metal-metal hip implants. J Biomed Mater Res B Appl Biomater 2004 ; 70 : 167-178
46. Billi F , Benya P , Kavanaugh A , Adams J , McKellop H , Ebramzadeh E. The John Charnley Award: An accurate and extremely sensitive method to separate, display, and characterize wear debris: Part 2: Metal and ceramic particles. Clin Orthop 2012 ; 470 : 339-350
47. Catelas I , Bobyn JD , Medley JB , Krygier JJ , Zukor DJ , Huk OL. Size, shape, and composition of wear particles from metal-metal hip simulator testing: Effects of alloy and number of loading cycles. J Biomed Mater Res Part A 2003 ; 67 : 312-327
48. Groth HE , Shilling JM. Tissue response to carbon-reinforced polyethylene. J Orthop Res 1983; 1: 129-135
49. Debnath UK , Fairclough JA , Williams RL. Long-term local effects of carbon fi bre in the knee. Knee 2004 ; 11 : 259-264
50. Brent J , Devlin JJ. Commentary. Dilemmas about the toxicological consequences of metal-on-metal hip prostheses-What we do and do not know, and what we should do? Clin Toxicol 2013 ; 51 : 195-198
51. USFDA (United States Food and Drug Administration). FDA Executive Summary Memorandum. Metal-on-Metal Hip Implant Systems. Prepared for the June 27-28, 2012 Meeting of the Orthopaedic and Rehabilitation Devices Advisory Panel Gaithersburg Hilton -Gaithersburg, Maryland 2012
52. USFDA (United States Food and Drug Administration). I nformation about Soft Tissue Imaging and Metal Ion Testing. Retrieved on April 25, 2013, from: Http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ ImplantsandProsthetics/MetalonMetal-HipImplants/ucm331971.htm. Silver Spring, MD: U.S. Food and Drug Administration ; 2013
53. Griffi n WL , Fehring TK , Kudrna JC , Schmidt RH , Christie MJ , Odum SM , Dennos AC. Are metal ion levels a useful trigger for surgical intervention? J Arthroplasty 2012 ; 27 : 32-36
54. N ewton A W, R anganath L , A rmstrong C , P eter V , R oberts N B. Differential distribution of cobalt, chromium, and nickel between whole blood, plasma and urine in patients after metal-on-metal (mom) hip arthroplasty. J Orthop Res 2012 ; 30 : 1640-1646
55. Finley BL , Unice KM , Kerger BD , Otani JM , Paustenbach DJ , Galbraith DA , et al. 31-day study of cobalt (II) chloride ingestion in humans: Pharmacokinetics and clinical effects. J Tox Enviro Health Part A 2013 ; 76 : 1-14
56. Daniel J , Ziaee H , Pynsent PB , McMinn DJW. The validity of serum levels as a surrogate measure of systemic exposure to metal ions in hip replacement. J Bone Joint Surg Br 2007 ; 89 : 736-741
57. Gardner FH. The use of cobaltous chloride in the anemia associated with chronic renal disease. J Lab Clin Med 1953 ; 41 : 56-64
58. Rohn RJ , Bond WH. Observations on some hematological effects of cobalt-iron mixtures. Lancet 1953 ; 73 : 317-324
59. Rohn RJ , Bond WH , Klotz LJ. The effect of cobalt-iron therapy in iron defi ciency anemia in infants. J Indiana State Med Assoc 1953 ; 46 : 1253-1260
60. Taylor A , Marks V , Shabaan AA , Mahmood HA , Duckham JM , Lee HA. Cobalt-induced lipaemia and erythropoiesis. Clinical Chemistry and Chemical Toxicology of Metals: Proc First Int Symp 1977 : 105-108
61. Wolf J , Levy IJ. Treatment of sickle cell anemia with cobalt chloride. Arch Intern Med 1954 ; 93 : 387-396
62. Wright JV. Bio-identical steroid hormone replacement: Selected observations from 23 years of clinical and laboratory practice. Ann NY Acad Sci 2005 ; 1057 : 506-524
63. Kesteloot H , Roelandt J , Willems J , Claes JH , Joossens JV. An enquiry into the role of cobalt in the heart disease of chronic beer drinkers. Circulation 1968 ; 37 : 854-864
64. P austenbach D J, T vermoes B E, O tani J M, U nice K M, F inley B L, Galbraith DA. Abstract Number 2556/Poster Board-144. Cobalt blood concentrations and health effects in adult volunteers during a 90-day cobalt supplement ingestion study. In: Society of Toxicology, ed. Society of Toxicologys (SOT) 52nd Annual Meeting, March 10-14, 2013, 2013 Annual Meeting Abstract Supplement: Late-Breaking Abstract Submissions. Reston, VA: Society of Toxicology. 2013 : 24-25
65. Bowie EA , Hurley PJ. Cobalt chloride in the treatment of refractory anaemia in patients undergoing long-term haemodialysis ; Aust NZ J Med 1975 ; 5 : 306-314
66. L icht A , O liver M , R achmilewitz E A. O ptic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. I sr J Med Sci 1 972; 8 : 6 1-6 6
67. Duckham JM , Lee HA. The treatment of refractory anaemia of chronic renal failure with cobalt chloride. Quart J Med 1976 ; 45 : 277-294
68. M eecham H M, H umphrey P. I ndustrial exposure to cobalt causing optic atrophy and nerve deafness: A case report. J Neurol Neurosurg Psychiat 1991; 54: 374-375
69. Schirrmacher UO. Case of cobalt poisoning. Br Med J 1967 ; 1 : 544-545
70. Schleisner P. Cobalt in anaemia. Acta Med Scand 1956 ; 154 : 177-185
71. Kriss JP , Carnes WH , Gross RT. Hypothyroidism and thyroid hyperplasia in patients treated with cobalt. JAMA 1955 ; 157 : 117-121
72. Davis JE , Fields JP. Experimental production of polycythemia in humans by administration of cobalt chloride. Proc Soc Exp Biol Med 1958 ; 99 : 493-495
73. Sidell CM , Erickson JG , McCleary JE. Cobalt folliculitis. Calif Med 1958 ; 88 : 20-21
74. Veien NK , Kaaber K. Nickel, cobalt and chromium sensitivity in patients with pompholyx (dyshidrotic eczema). Contact Dermatitis 1979 ; 5 : 371-374
75. Holly RG. Anemia in pregnancy. Obstet Gynecol 1955 ; 5 : 562-568
76. F rigerio E , P igatto P D, G uzzi G , A ltomare G. M etal sensitivity in patients with orthopaedic implants: A prospective study. Contact Dermatitis 2011 ; 64 : 273-279
77. Waterman AH , Schrik JJ. Allergy in hip arthroplasty. Contact Dermatitis 1985 ; 13 : 294-301
78. D eutman R , M ulder T J, B rian R , N ater J P. M etal sensitivity before and after total hip arthroplasty. J Bone Joint Surg Am 1977; 59: 862-865
79. Kwon YM , Thomas P , Summer B , Pandit H , Taylor A , Beard D , et al. Lymphocyte proliferation responses in patients with pseudotumors following metal-on-metal hip resurfacing arthroplasty. J Orthop Res 2010 ; 28 : 444-450
80. Park YS , Moon YW , Lim SJ , Yang JM , Ahn G , Choi YL. Early osteolysis following second-generation metal-on-metal hip replacement. J Bone Joint Surg Am 2005 ; 87 : 1515-1521
81. Thomas P , Braathen LR , Dorig M , Aubock J , Nestle F , Werfel T , Willert HG. Increased metal allergy in patients with failed metal-onmetal hip arthroplasty and peri-implant T-lymphocytic infl ammation. Allergy 2009 ; 64 : 1157-1165
82. Korovessis P , Petsinis G , Repanti M , Repantis T. Metallosis after contemporary metal-on-metal total hip arthroplasty. Five to nineyear follow-up. J Bone Joint Surg Am 2006 ; 88 : 1183-1191
83. Shahrdar C , Campbell P , Mirra J , Dorr LD. Painful metal-on-metal total hip arthroplasty. J Arthroplasty 2006 ; 21 : 289-293
84. Polyzois I , Nikolopoulos D , Michos I , Patsouris E , Theocharis S. Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. J Appl Toxicol 2012 ; 32 : 255-269
85. Gill HS , Grammatopoulos G , Adshead S , Tsialogiannis E , Tsiridis E. Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty. Trends Mol Med 2012 ; 18 : 145-155
86. Billi F , Campbell P. Nanotoxicology of metal wear particles in total joint arthroplasty: A review of current concepts. J Appl Biomater Biomech 2010 ; 8 : 1-6
87. Papageorgiou I , Brown C , Schins R , Singh S , Newson R , Davis S , et al. The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fi broblasts in vitro. Biomaterials 2007 ; 28 : 2946-2958
88. Brown C , Fisher J , Ingham E. Biological effects of clinically relevant wear particles from metal-on-metal hip prostheses. Proc Inst Mech l Eng Part H J Eng Med 2006 ; 220 : 355-369
89. Brown C , Lacharme-Lora L , Mukonoweshuro B , Sood A , Newson RB , Fisher J, et al. Consequences of exposure to peri-Articular injections of micro- and nano-particulate cobalt-chromium alloy. Biomaterials 2013; 34: 8564-8580
90. Behl B , Papageorgiou I , Brown C , Hall R , Tipper JL , Fisher J , Ingham E. Biological effects of cobalt-chromium nanoparticles and ions on dural fi broblasts and dural epithelial cells. Biomaterials 2013 ; 34 : 3547-3558
91. Raghunathan VK , Devey M , Hawkins S , Hails L , Davis SA , Mann S , et al. Infl uence of particle size and reactive oxygen species on cobalt chrome nanoparticle-mediated genotoxicity. Biomaterials 2013 ; 34 : 3559-3570
92. Parry MC , Bhabra G , Sood A , Machado F , Cartwright L , Saunders M , et al. Thresholds for indirect DNA damage across cellular barriers for orthopaedic biomaterials. Biomaterials 2010 ; 31 : 4477-4483
93. B habra G , S ood A , F isher B , C artwright L , S aunders M , E vans W H, et al. Nanoparticles can cause DNA damage across a cellular barrier. Nature Nanotechnol 2009 ; 4 : 876-883
94. Germain MA , Hatton A , Williams S , Matthews JB , Stone MH , Fisher J , Ingham E. Comparison of the cytotoxicity of clinically relevant cobalt-chromium and alumina ceramic wear particles in vitro. Biomaterials 2003 ; 24 : 469-479
95. Doorn PF , Campbell PA , Worrall J , Benya PD , McKellop HA , Amstutz HC. Metal wear particle characterization from metal on metal total hip replacements: Transmission electron microscopy study of periprosthetic tissues and isolated particles. J Biomed Mater Res 1998 ; 42 : 103-111
96. Goode AE , Perkins JM , Sandison A , Karunakaran C , Cheng H , Wall D , et al. Chemical speciation of nanoparticles surrounding metal-on-metal hips. Chem Commun 2012 ; 48 : 8335-8337
97. Pourzal R , Catelas I , Theissmann R , Kaddick C , Fischer A. Characterization of wear particles generated from CoCrMo alloy under sliding wear conditions. Wear 2011 ; 271 : 1658-1666
98. Lewis AC , Heard PJ. The effects of calcium phosphate deposition upon corrosion of CoCr alloys and the potential for implant failure. J Biomed Mater Res Part A 2005 ; 75 : 365-373
99. Lewis AC , Kilburn MR , Papageorgiou I , Allen GC , Case CP. Effect of synovial fl uid, phosphate-buffered saline solution, and water on the dissolution and corrosion properties of CoCrMo alloys as used in orthopedic implants. J Biomed Mater Res Part A 2005 ; 73A : 456-467
100. Hokin B , Adams M , Ashton J , Louie H. Comparison of the dietary cobalt intake in three different Australian diets. Asia Pac J Clin Nutr 2004 ; 13 : 289-291
101. Hokin B , Adams M , Ashton J , Louie H. Analysis of the cobalt content in Australian foods. Asia Pac J Clin Nutr 2004 ; 13 : 284-288
102. EGVM (Expert Group on Vitamins and Minerals). Safe Upper Levels for Vitamins and Minerals. London: Food Standards Agency ; 2003
103. EFSA (European Food Safety Authory). Assessment of the safety of cobalt(II) chloride hexahydrate added for nutritional purposes as a source of cobalt in food supplements and the bioavailability of cobalt from this source. EFSA J 2009 ; 7 : 1-8
104. Mineralife. C obalt - Liquid Ionic Supplement. Retrieved on July 31, 2012, from: Http://www.ionicliquidminerallife.com/ionic/Cobalt-trace-Mineral-b- 1029.asp. Colorado Springs, CO: Mineralife; 2012
105. Mineralife. C obalt 8oz -120 Day Supply. Retrieved on December 6, 2012, from:- http://www.mineralifeonline.com/pd-cobalt-8oz-60-day-supply.cfm. Colorado Springs, CO: Mineralife ; 2012
106. Meltzer HM , Brantsaeter AL , Borch-Iohnsen B , Ellingsen DG , Alexander J , Thomassen Y , et al. Low iron stores are related to higher blood concentrations of manganese, cobalt and cadmium in non-smoking, Norwegian women in the HUNT 2 study. Environ Res 2010 ; 110 : 497-504
107. Reuber S , Kreuzer M , Kirchgessner M. Interactions of cobalt and iron in absorption and retention. J Trace Elem Electrolytes Health Dis 1994 ; 8 : 151-158
108. Bar-Or D , Rael LT , Bar-Or R , Slone DS , Mains CW , Rao NK , Curtis CG. The cobalt-Albumin binding assay: Insights into its mode of action. Clin Chim Acta 2008 ; 387 : 120-127
109. Kerger BD , Gerads R , Gurleyuk H , Thuett KA , Finley BL , Paustenbach DJ. Cobalt speciation assay for human serum. Part I. Method for measuring large and small molecular cobalt and albumin-binding capacity using size exclusion chromatography with inductively-coupled plasma-mass spectroscopy detection. Toxicol Environ Chem 2013 ; 95 : 687-708
110. Kerger BD , Tvermoes B , Unice K , Finley BL , Paustenbach DJ , Galbraith D. Cobalt speciation assay for human serum. Part II. Method validation in a study of human volunteers ingesting Cobalt (II) Chloride Dietary Supplement for 90 days. Toxicol Environ Chem 2013 ; 95 : 709-718
111. Bar-Or D , Bar-Or R , Rael LT , Gardner DK , Slone DS , Craun ML. Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 2005 ; 33 : 1638-1641
112. Bar-Or D , Winkler JV , Vanbenthuysen K , Harris L , Lau E , Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001 ; 141 : 985-991
113. Mothes E , Faller P. Evidence that the principal CoII-binding site in human serum albumin is not at the N-terminus: Implication on the albumin cobalt binding test for detecting myocardial ischemia. Biochemistry (Mosc). 2007 ; 46 : 2267-2274
114. Sadler PJ , Tucker A , Viles JH. Involvement of a lysine residue in the N-terminal Ni2 and Cu2- binding site of serum albumins. Comparison with Co2 , Cd2 and Al3. Eur J Biochem 1994 ; 220 : 193-200
115. Unice K , Monnot A , Gaffney SH , Tvermoes B , Thuett K , Paustenbach D, et al. Inorganic cobalt supplementation: Prediction of cobalt levels in whole blood and urine using a biokinetic model. Food Chem Toxicol 2012 ; 50 : 2456-2461
116. Tvermoes BE , Finley BL , Unice KM , Otani JM , Paustenbach DJ , Galbraith DA. Cobalt whole blood concentrations in healthy adult male volunteers following two-weeks of ingesting a cobalt supplement. Food Chem Toxicol 2013 ; 53 : 432-439
117. Tevetoglu F. The treatment of common anemias in infancy and childhood with a cobalt-iron mixture; including a case report of iron defi ciency anemia due to geophagia. J Pediatr 1956 ; 49 : 46-55
118. Alexander C S. C obalt-beer cardiomyopathy: A clinical and pathologic study of twenty-eight cases. Am J Med 1972 ; 53 : 395-417
119. Steens W , von Foerster G , Katzer A. Severe cobalt poisoning with loss of sight after ceramic-metal pairing in a hip-A case report. Acta Orthop 2006 ; 77 : 830-832
120. Oldenburg M , Wegner R , Baur X. Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. J Arthroplasty 2009 ; 24 : 825.e815-825.e820
121. Rizzetti MC , Liberini P , Zarattini G , Catalani S , Pazzaglia U , Apostoli P , Padovani A. Loss of sight and sound. Could it be the hip? Lancet 2009 ; 373 : 1052-1052
122. Ikeda T , Takahashi K , Kabata T , Sakagoshi D , Tomita K , Yamada M. Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement. Muscle Nerve 2010 ; 42 : 140-143
123. Pelclova D , Sklensky M , Janicek P , Lach K. Severe cobalt intoxication following hip replacement revision: Clinical features and outcome. Clin Toxicol 2012 ; 50 : 262-265
124. Zywiel MG , Brandt JM , Overgaard CB , Cheung AC , Turgeon TR , Syed KA. Fatal cardiomyopathy after revision total hip replacement for fracture of a ceramic liner. J Bone Joint Surg Br 2013 ; 95 : 31-37
125. Janicek P , Tomas T , Klepac L , Pelclova D , Sklensky M. Chronic intoxication with cobalt following revision total hip arthroplasty. Hip Int 2012;[Online] Available at: Http://www.hip-int.com/article/chronic-intoxication- with-cobalt-following-revision-total-hiparthroplasty. Accessed 1 November 2012
126. A pel W , S tark D , S tark A , O H agan S , L ing J. C obalt-chromium toxic retinopathy case study. Doc Ophthalmol 2013; 126: 69-78
127. Pazzaglia UE , Apostoli P , Congiu T , Catalani S , Marchese M , Zarattini G. Cobalt, chromium and molybdenum ions kinetics in the human body: Data gained from a total hip replacement with massive third body wear of the head and neuropathy by cobalt intoxication. Arch Orthop Trauma Surg 2011 ; 131 : 1299-1308
128. Tower SS. Arthroprosthetic cobaltism: Neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: A case report. J Bone Joint Surg Am 2010 ; 92 : 2847-2851
129. Mao X , Wong AA , Crawford RW. Cobalt toxicity - An emerging clinical problem in patients with metal-on-metal hip prostheses? Med J Aust 2011 ; 194 : 649-651
130. Machado C , Appelbe A , Wood R. Arthroprosthetic cobaltism and cardiomyopathy. Heart Lung Circ 2012; 21: 759-760
131. Ng SK , Ebneter A , Gilhotra JS. Hip-implant related chorio-retinal cobalt toxicity. Indian J Ophthalmol 2013 ; 61 : 35-37
132. Sotos JG , Tower SS. Systemic disease after hip replacement: Aeromedical implications of arthroprosthetic cobaltism. Aviat Space Environ Med 2013 ; 84 : 242-245
133. Leikin JB , Karydes HC , Whiteley PM , Wills BK , Cumpston KL , Jacobs JJ. Outpatient toxicology clinic experience of patients with hip implants. Clin Toxicol 2013 ; 51 : 230-236
134. Moretti B , Pesce V , Maccagnano G , Vicenti G , Lovreglio P , Soleo L , Apostoli P. Peripheral neuropathy after hip replacement failure: Is vanadium the culprit? Lancet 2012 ; 379 : 1676
135. Angell M. Shattuck Lecture-Evaluating the health risks of breast implants: The interplay of medical science, the law, and public opinion. N Engl J Med 1996 ; 334 : 1513-1518
136. Palcheff-Wiemer M , Concannon MJ , Conn VS , Puckett CL. The impact of the media on women with breast implants. Plast Reconstr Surg 1993 ; 92 : 779-785
137. P rentice J R, C lark M J, H oggard N , M orton A C, T ooth C , P aley M N, et al. Metal-on-metal hip prostheses and systemic health: A crosssectional association study 8 years after implantation. PLoS One 2013 ; 8 : E66186-e66195
138. Alimonti A , Bocca B , Mannella E , Petrucci F , Zennaro F , Cotichini R , et al. Assessment of reference values for selected elements in a healthy urban population. Ann Ist Super Sanita 2005 ; 41 : 181-187
139. Minoia C , Sabbioni E , Apostoli P , Pietra R , Pozzoli L , Gallorini M , et al. Trace element reference values in tissues from inhabitants of the European community. I. A study of 46 elements in urine, blood and serum of Italian subjects. Sci Total Environ 1990 ; 95 : 89-105
140. Anard D , Kirsch-Volders M , Elhajouji A , Belpaeme K , Lison D. In vitro genotoxic effects of hard metal particles assessed by alkaline single cell gel and elution assays. Carcinogenesis 1997 ; 18 : 177-184
141. Van Goethem F , Lison D , Kirsch-Volders M. Comparative evaluation of the in vitro micronucleus test and the alkaline single cell gel electrophoresis assay for the detection of DNA damaging agents: Genotoxic effects of cobalt powder, tungsten carbide and cobalttungsten carbide. Mutat Res 1997 ; 392 : 31-43
142. C olognato R , B onelli A , P onti J , F arina M , B ergamaschi E , Sabbioni E , Migliore L. Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. Mutagenesis 2008 ; 23 : 377-382
143. Alarifi S , Ali D , Suliman Y AO , Ahamed M , Siddiqui MA , Al-Khedhairy AA. Oxidative stress contributes to cobalt oxide nanoparticles-induced cytotoxicity and DNA damage in human hepatocarcinoma cells. Int J Nanomedicine 2013 ; 8 : 189-199
144. De Boeck M , Lombaert N , De Backer S , Finsy R , Lison D , Kirsch-Volders M. In vitro genotoxic effects of different combinations of cobalt and metallic carbide particles. Mutagenesis 2003 ; 18 : 177-186
145. Stea S , Visentin M , Granchi D , Savarino L , Dallari D , Gualtieri G , et al. Sister chromatid exchange in patients with joint prostheses. J Arthroplasty 2000 ; 15 : 772-777
146. Ladon D , Doherty A , Newson R , Turner J , Bhamra M , Case CP. Changes in metal levels and chromosome aberrations in the peripheral blood of patients after metal-on-metal hip arthroplasty. J Arthroplasty 2004 ; 19 : 78-83
147. Daley B , Doherty AT , Fairman B , Case CP. Wear debris from hip or knee replacements causes chromosomal damage in human cells in tissue culture. J Bone Joint Surg Br 2004 ; 86 : 598-606
148. Davies AP , Sood A , Lewis AC , Newson R , Learmonth ID , Case CP. Metal-specifi c differences in levels of DNA damage caused by synovial fl uid recovered at revision arthroplasty. J Bone Joint Surg Br 2005 ; 87 : 1439-1444
149. Collins A , Dusinska M , Franklin M , Somorovska M , Petrovska H , Duthie S , et al. Comet assay in human biomonitoring studies: Reliability, validation, and applications. Environ Mol Mutagen 1997 ; 30 : 139-146
150. Olsen JH , McLaughlin JK , Nyren O , Mellemkjaer L , Lipworth L , Blot WJ , et al. Hip and knee implantations among patients with osteoarthritis and risk of cancer: A record-linkage study from Denmark. Int J Cancer 1999 ; 81 : 719-722
151. Visuri T , Pukkala E , Pulkkinen P , Paavolainen P. Decreased cancer risk in patients who have been operated on with total hip and knee arthroplasty for primary osteoarthrosis: A meta-Analysis of 6 Nordic cohorts with 73,000 patients. Acta Orthop Scand 2003 ; 74 : 351-360
152. V isuri T I, P ukkala E , P ulkkinen P , P aavolainen P. C ancer incidence and causes of death among total hip replacement patients: A review based on Nordic cohorts with a special emphasis on metal-on-metal bearings. Proc Inst Mech l Eng Part H J Eng Med 2006 ; 220 : 399-407
153. Smith AJ , Dieppe P , Porter M , Blom AW. Risk of cancer in fi rst seven years after metal-on-metal hip replacement compared with other bearings and general population: Linkage study between the National Joint Registry of England and Wales and hospital episode statistics. BMJ 2012 ; 344 : E2383-e2394
154. Lalmohamed A , MacGregor AJ , de Vries F , Leufkens HGM , van Staa TP. Patterns of risk of cancer in patients with metal-onmetal hip replacements versus other bearing surface types: A record linkage study between a prospective joint registry and general practice electronic health records in England. PLoS One 2013 ; 8 : E65891
155. Paavolainen P , Pukkala E , Pulkkinen P , Visuri T. Cancer incidence after total knee arthroplasty: A nationwide Finnish cohort from 1980 to 1996 involving 9,444 patients. Acta Orthop Scand 1999 ; 70 : 609-617
156. Paavolainen P , Pukkala E , Pulkkinen P , Visuri T. Cancer incidence in Finnish hip replacement patients from 1980 to 1995 : A nationwide cohort study involving 31,651 patients. J Arthroplasty 1999; 14 : 272-280
157. Visuri T , Koskenvuo M. Cancer risk after McKee-Farrar total hip replacement. Orthopedics 1991 ; 14 : 137-142
158. Visuri T , Pukkala E , Paavolainen P , Pulkkinen P , Riska EB. Cancer risk after metal on metal and polyethylene on metal total hip arthroplasty. Clin Orthop 1996 ; 329 : S280-S289
159. Visuri T , Borg H , Pulkkinen P , Paavolainen P , Pukkala E. A retrospective comparative study of mortality and causes of death among patients with metal-on-metal and metal-on-polyethylene total hip prostheses in primary osteoarthritis after a long-term follow-up. BMC Musculoskel Dis 2010 ; 11 : 1-8
160. Visuri T , Pulkkinen P , Paavolainen P , Pukkala E. Cancer risk is not increased after conventional hip arthroplasty. A nationwide study from the Finnish Arthroplasty Register with follow-up of 24,636patients for a mean of 13 years. Acta Orthop 2010 ; 81 : 77-81
161. Gillespie W , Frampton C , Henderson R , Ryan P. The incidence of cancer following total hip replacement. J Bone Joint Surg Br 1988 ; 70 : 539-542
162. Mathiesen EB , Ahlbom A , Bermann G , Lindgren JU. Total hip replacement and cancer: A cohort study. J Bone Joint Surg Br 1995 ; 77 : 345-350
163. Nyren O , McLaughlin JK , Gridley G , Ekbom A , Johnell O , Fraumeni JF Jr , Adami HO. Cancer risk after hip replacement with metal implants: A population-based cohort study in Sweden. J Natl Cancer Inst 1995 ; 87 : 28-33
164. Signorello LB , Ye W , Fryzek JP , Lipworth L , Fraumeni JF , Blot WJ , et al. Nationwide study of cancer risk among hip replacement patients in Sweden. J Natl Cancer Inst 2001 ; 93 : 1405-1410
165. Holly RG. Studies on iron and cobalt metabolism. JAMA 1955 ; 158 : 1349-1352
166. J aimet C H, T hode H G. T hyroid function studies on children receiving cobalt therapy. JAMA 1955 ; 158 : 1353-1355
167. Angerer J , Heinrich R , Szadkowski D , Lehnert G. Occupational exposure to cobalt powder and salts biological monitoring and health effects. In: Lekkas TD , ed. International Conference Heavy Metals in the Environment: Athens, September 1985, Volume 2. Edinburgh, Scotland, UK: CEP Consultants ; 1985 : 11-13
168. Raffn E , Mikkelsen S , Altman DG , Christensen JM , Groth S. Health effects due to occupational exposure to cobalt blue dye among plate painters in a porcelain factory in Denmark. Scand J Work Environ Health 1988 ; 14 : 378-384
169. Swennen B , Buchet JP , Stanescu D , Lison D , Lauwerys R. Epidemiological survey of workers exposed to cobalt oxides, cobalt salts, and cobalt metal. Br J Ind Med 1993 ; 50 : 835-842
170. Lantin AC , Mallants A , Vermeulen J , Speybroeck N , Hoet P , Lison D. Absence of adverse effect on thyroid function and red blood cells in a population of workers exposed to cobalt compounds. Toxicol Lett 2011 ; 201 : 42-46
171. Jacquet M. Huit annes de cobaltotherapie en cardiologie. Arch Mal Coeur Vaiss 1949 ; 42 : 1095-1111
172. Mohiuddin SM , Taskar PK , Rheault M , Roy PE , Chenard J , Morin Y. Experimental cobalt cardiomyopathy. Am Heart J 1970; 80 : 532-543
173. Domingo JL , Llobet JM , Bernat R. A study of the effects of cobalt administered orally to rats. Arch Farmacol Toxicol 1984 ; 10 : 13-20
174. Morvai V , Szakmary E , Tatrai E , Ungvary G , Folly G. The effects of simultaneous alcohol and cobalt chloride administration on the cardiovascular system of rats. Acta Physiol Hung 1993 ; 81 : 253-261
175. H aga Y , C line N , H atori N , H offmann-Bang C , P ehrsson S K, Ryden L. Impaired myocardial function following chronic cobalt exposure in an isolated rat heart model. Trace Elem Electrolyt 1996 ; 13 : 69-74
176. R oche M , L ayrisse M. E ffect of cobalt on thyroidal uptake of I131.J Clin Endocrinol Metab 1956 ; 16 : 831-833